ADORA3 and astrocytoma (excluding glioblastoma): It should be recalled that in contrast to the data reported in the studies mentioned above, two early investigations indicate that this A3AR agonist drug stimulated proliferation of both human colon cancer and astrocytoma cells (46, 47).